Azithromycin Plus Chloroquine Versus Atovaquone-Proguanil For The Treatment Of Uncomplicated Plasmodium Falciparum Malaria In South America

• Status: Completed
• Trial end date: 2005-07-01

Summary

The primary objective is to confirm the hypothesis that azithromycin plus chloroquine is non-inferior to atovaquone-proguanil for the treatment of symptomatic, uncomplicated malaria due to P. falciparum.

• Phase: Phase 2/Phase 3

Details

• Lead Sponsor: Pfizer
• Treatments: Atovaquone; Atovaquone, proguanil drug combination; Azithromycin; Chloroquine; Chloroquine diphosphate; Proguanil